{
    "nctId": "NCT04824339",
    "briefTitle": "Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.",
    "officialTitle": "Breast Cancer Endocrine Therapy FITness (BE-FIT) Trial.",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 132,
    "primaryOutcomeMeasure": "Physical Function",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Stage I - III breast cancer patients who are treated with curative intent\n* Completed primary treatment, including surgery, radiation therapy and/or chemotherapy\n* Currently receiving adjuvant endocrine therapy (Tamoxifen or an Aromatase Inhibitor) for at least 3 months (to allow for acclimatization) and within 3-years of of staring endocrine therapy.\n* Can read and speak English\n* Has access to a tablet, smartphone, laptop or computer with built-in video camera\n\nExclusion Criteria:\n\n* Not currently receiving endocrine therapy or scheduled to stop within 6 months\n* Diagnosed with stage IV breast cancer\n* Not willing to attend a twice-weekly exercise program virtually for the duration of the study.\n* Not willing to comply with safety measures of virtual programming (to be seen on camera and monitored via video by the instructor)",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}